The how to dose semaglutide protocol is the baseline titration curve I'd recommend establishing before introducing the glucagon-axis variables covered in the retatrutide titration protocol
PROMISING POTENTIAL GLP-1RAs offer a promising outlook as transformative therapies in glycemic control, weight management, neuroprotection, and cardiovascular and renal protection
hypertension, type 2 DM, dyslipidemia) A meta-analysis of 22 trials involving over 17,000 patients determined that 50.2% and 17.5% of patients treated with GLP-1RAs (exenatide, semaglutide & liraglutide) experienced a weight loss of 5% and 10% compared to placebo, and that patients without type 2 diabetes achieved a significantly greater weight loss compared to those with diabetes (Vosoughi et al, 2022)
Researchers continue to study the long-term effects of newer GLP-1 medications, including their impact on lean muscle mass
When butyrate binds to free fatty acid receptor 2 (FFAR2) and free fatty acid receptor 3 (FFAR3) on intestinal L cells, it stimulates GLP-1 release